Direct, grounded answers to the questions most visitors arrive with — including the hard ones about Royal Rife's reputation, the scammer layer that formed around his name, and what Rife Systems is and is not.
Yes, provably so. His peer-reviewed work appeared in California and Western Medicine (co-authored with Professor Arthur Isaac Kendall of Northwestern University Medical School, 1931), in Science (the AAAS flagship journal, published observations by E. C. Rosenow of the Mayo Clinic in 1932), in the Journal of the Franklin Institute (1944), and in the Annual Report of the Board of Regents of the Smithsonian Institution (1944). His instruments were built by his own Laboratory of Research Bacteriology in San Diego and were used by named academic researchers at Northwestern, Mayo Clinic, USC, and other institutions.
These are verifiable facts recorded in the indexed scientific literature of his era. Anyone can look up those journal citations.
Royal Rife himself — in his published papers — never made that public claim. His published work is about optical instrumentation and direct observation of microorganisms, not treatment claims.
The claim that "Rife cured cancer" became associated with his name largely after the 1934 USC Special Medical Research Committee investigation — a real historical event led by Dr. Milbank Johnson of USC — and through the work of later authors interpreting that committee's records. The historical record of that committee is genuine; the interpretations layered on top of it over subsequent decades are often not.
Rife Systems does not make cancer treatment claims. We present the published record and let readers evaluate it for themselves.
Three reasons, in order of historical weight:
First — during his lifetime, professional conflict with segments of the American medical establishment (notably figures associated with the AMA under Morris Fishbein's editorship of JAMA) meant that Rife's instruments and methods were not absorbed into mainstream medical practice. That's a historical fact with documentary support; how it's been interpreted varies widely.
Second — in the decades following his death in 1971, entrepreneurs and promoters attached his name to products he never designed, frequencies he never specified, and therapeutic claims he never published. A whole industry of "Rife machines" emerged, much of it run by people with no connection to him, his family, or his research. Some of that industry has been honest; some has been actively fraudulent. The FDA and consumer-protection agencies have rightly acted against bad actors. But that action — correctly targeting fraud — has also broadly tarnished the name.
Third — academic science, when confronted with the combination of (1) a real historical researcher, (2) a broken documentary trail between his death and the modern era, and (3) a loud fringe industry trading on his name, has usually chosen the simplest response: dismiss the whole area as pseudoscience. That dismissal is understandable given the noise, but it conflates the man with the bad actors.
Rife Systems exists to separate those three layers and present only the first: the documented, peer-reviewed, institutionally-recognized record of a real scientist.
Professor Emeritus of Physiological Therapeutics at the USC College of Medicine, and chairman of the AMA Southern California Division during his active career. Dr. Johnson convened the USC Special Medical Research Committee in 1931 to investigate Rife's instruments and methods — a committee that included named academic pathologists and physicians. Historical records of that committee exist in various archives; what has been reported about its conclusions varies significantly depending on source.
Documented, verifiable innovations in optical engineering:
Sub-stage illumination (the Rife Lamp) — adopted by other microscope manufacturers of the era including Otto Himmler of Berlin.
All-quartz optical paths — to transmit the full ultraviolet spectrum for fluorescence and polarization microscopy.
Double-wedge rotating quartz prism — for precise control of polarized-light illumination at any angle.
Horizontal optical-bench microscope architecture — an engineering departure from conventional vertical-column designs.
Working resolution approximately 20 angstroms — verified by 1970s pathology review of the 1944 Smithsonian-published photographs, later corroborated by electron microscopy.
See the Legacy page for full context, and the Research Archive for citations.
Yes — research on the underlying mechanism. Zimmerman et al. published a 2013 paper in the Chinese Journal of Cancer demonstrating that specific amplitude-modulated radiofrequency electromagnetic fields produce tissue- and tumor-specific cellular effects in vitro — specifically, regulation of genes involved in migration and invasion, and disruption of the mitotic spindle. The senior author, Boris Pasche, is a well-known clinical oncologist. Related work by Barbault et al. (2009) and Costa et al. (British Journal of Cancer, 2011) extended these findings to clinical populations.
This is not a claim that Rife's specific historical frequencies have been validated. It is the modern confirmation that the underlying mechanism — tissue-specific response to specific amplitude-modulated electromagnetic frequencies — is real and measurable under peer-reviewed conditions.
See the Research Archive for full citations.PEMF — Pulsed Electromagnetic Field therapy — is an FDA-cleared modality used in orthopedics for non-union fracture healing. It operates on the same general principle of frequency-specific biological response that underlies the field Rife worked in.
The foundational clinical review by C. A. L. Bassett in Critical Reviews in Biomedical Engineering (1989), and the mechanistic work of Arthur Pilla, establish PEMF as legitimate mainstream medicine with extensive peer-reviewed literature. A 2009 paper in Aesthetic Surgery Journal on PEMF for surgical wound healing was co-authored by Nobel laureate Louis Ignarro.
MEG is the mainstream neuroscience technique for measuring the tiny magnetic fields produced by electrical activity in the human brain. It was introduced in Science by David Cohen in 1972 and has been a standard clinical modality for decades — used in presurgical epilepsy planning, cognitive neuroscience research, and neurological diagnostics.
Rife Systems mentions MEG because it establishes, at the highest level of scientific rigor, that biological tissue both produces and responds to electromagnetic signals at specific frequencies. The underlying principle — that living systems are electromagnetically active in frequency-specific ways — is settled mainstream science. What Rife was researching in his era was a specific application of that general principle.
Matthew Rife is Dr. Royal Raymond Rife's great-nephew and the founder of Rife Systems. He has run legitimate hardware manufacturing operations in this space previously (with prior revenue of approximately $2 million per year and eight employees at peak). Following a period of personal and financial reconsolidation, he is restarting the business in Philadelphia on a leaner operating model and a cleaner brand.
Matthew is the author of Foundations of Rife Therapy, available on Amazon, and the principal instructor for the Rife-related courses offered through Apex Online Academy (his education platform).
No. Our instruments are sold for research, educational, and experimental use only. They are not medical devices; they are not marketed for diagnosis, treatment, cure, or mitigation of any disease; they are not FDA-cleared for any medical indication; and we do not provide medical advice.
Customers use our instruments for research into the properties of amplitude-modulated and frequency-specific electromagnetic signaling, for educational demonstration of principles described in the published literature, and for continuation of the optical-engineering tradition that Dr. Rife established.
Four ways:
Direct lineage — Matthew Rife is family, with access to original documentation and instruments.
Primary-source grounding — every technical specification is traceable to documented published work, not to post-1971 hearsay or secondary frequency lists.
Educational framing, not medical — we do not claim cures, do not prescribe frequencies for specific conditions, and actively refuse the marketing language that has damaged the field.
Transparent sourcing — our Research Archive lists every peer-reviewed paper we draw from. We publish our reasoning; we do not ask you to trust us.
Yes. The chat icon in the lower right of every page opens our research assistant, which is grounded in a curated 1.5-million-word corpus of primary-source and peer-reviewed literature about Dr. Rife's work and related modern research. It cites its sources with every answer, hedges appropriately, and refuses to make medical recommendations. The full chat system — with persistent conversation history for signed-in accounts — is rolling out in the coming days.
Yes — Matthew is fulfilling orders as of April 2026, with machines being built in Virginia during the pre-move period and production shifting to Philadelphia in the coming weeks. The online store on this website is launching shortly. For custom-configuration orders or specific technical requirements before the store goes live, please use the contact options on the main page.